Showing results (2101-2110 of 2,589) with videos related to

Sort By:
Pageof 259
Molecular Oncology|February 10, 2017
Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complexSara Weirich, Srikanth Kudithipudi, Albert Jeltsch
Molecular Oncology|March 2, 2017
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomesGiovanna Marziali, Mariachiara Buccarelli, Alessandro Giuliani, et al.
Molecular Oncology|February 12, 2017
CNOT1 cooperates with LMNA to aggravate osteosarcoma tumorigenesis through the Hedgehog signaling pathwayDong-Dong Cheng, Jing Li, Shi-Jie Li, et al.
Molecular Oncology|December 17, 2021
KRAS mutation-independent downregulation of MAPK/PI3K signaling in colorectal cancerKuen Kuen Lam, Choong Leong Tang, Emile Tan, et al.
Molecular Oncology|November 7, 2021
USP22-mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expressionDianyun Ren, Yan Sun, Dan Li, et al.
Molecular Oncology|November 8, 2021
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venuesAlexander Scheiter, Katja Evert, Lucas Reibenspies, et al.
Molecular Oncology|December 4, 2021
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinomaJohn Gallon, Mairene Coto-Llerena, Caner Ercan, et al.
Molecular Oncology|November 24, 2021
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trialTiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, et al.
Molecular Oncology|August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Molecular Oncology|August 4, 2019
Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals onSuchismita Mohanty, Maryam Aghighi, Ketan Yerneni, et al.
Pageof 259